EDITAS MEDICINE, INC. Capital Expenditures
EDITAS MEDICINE, INC. (EDIT) reported Capital Expenditures of $198.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $106.00K.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $92.00K, a 19.30% decline year-over-year.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $60.00K, a 88.89% decline year-over-year.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $433.00K, a 85.18% decline year-over-year.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $607.00K, a 93.12% decline from fiscal 2024.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $8.83M, a 87.03% increase from fiscal 2023.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $4.72M, a 14.59% increase from fiscal 2022.
- EDITAS MEDICINE, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $4.12M, a 48.38% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $198.00K 10-Q · filed 2026-08-05 | $258.00K derived: sum of 3 quarters · filed 2026-08-05 | $691.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $92.00K 10-Q · filed 2026-05-05 | $152.00K derived: sum of 2 quarters · filed 2026-05-05 | $585.00K derived: sum of 3 quarters · filed 2026-05-05 | $585.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $493.00K derived: sum of 2 quarters · filed 2026-03-09 | $493.00K derived: sum of 3 quarters · filed 2026-08-05 | $607.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $433.00K derived: sum of 2 quarters · filed 2026-08-05 | $547.00K 10-Q · filed 2025-11-10 | $1.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $114.00K 10-Q · filed 2026-08-05 | $654.00K derived: sum of 3 quarters · filed 2026-08-05 | $3.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $114.00K 10-Q · filed 2026-05-05 | $654.00K derived: sum of 2 quarters · filed 2026-05-05 | $3.58M derived: sum of 3 quarters · filed 2026-05-05 | $7.07M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.46M derived: sum of 2 quarters · filed 2026-03-09 | $6.96M derived: sum of 3 quarters · filed 2026-03-09 | $8.83M 10-K · filed 2026-03-09 |
| 2024-09-30 | $2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.42M derived: sum of 2 quarters · filed 2025-11-10 | $8.29M 10-Q · filed 2025-11-10 | $9.59M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $5.37M 10-Q · filed 2025-08-12 | $6.67M derived: sum of 3 quarters · filed 2025-08-12 | $6.91M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.87M 10-Q · filed 2025-05-12 | $3.18M derived: sum of 2 quarters · filed 2025-05-12 | $3.42M derived: sum of 3 quarters · filed 2025-05-12 | $4.75M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $1.55M derived: sum of 2 quarters · filed 2025-03-05 | $2.88M derived: sum of 3 quarters · filed 2025-03-05 | $4.72M 10-K · filed 2025-03-05 |
| 2023-09-30 | $239.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $1.57M derived: sum of 2 quarters · filed 2024-11-04 | $3.41M 10-Q · filed 2024-11-04 | $4.04M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.17M 10-Q · filed 2024-08-07 | $3.80M derived: sum of 3 quarters · filed 2025-03-05 | $4.41M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $1.84M 10-Q · filed 2024-05-08 | $2.46M derived: sum of 2 quarters · filed 2025-03-05 | $3.08M derived: sum of 3 quarters · filed 2025-03-05 | $3.71M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $1.24M derived: sum of 2 quarters · filed 2025-03-05 | $1.87M derived: sum of 3 quarters · filed 2025-03-05 | $4.12M 10-K · filed 2025-03-05 |
| 2022-09-30 | $614.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.25M derived: sum of 2 quarters · filed 2023-11-03 | $3.49M 10-Q · filed 2023-11-03 | $6.34M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $632.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.88M 10-Q · filed 2023-08-02 | $5.72M derived: sum of 3 quarters · filed 2024-02-28 | $8.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.25M 10-Q · filed 2023-05-05 | $5.09M derived: sum of 2 quarters · filed 2024-02-28 | $7.44M derived: sum of 3 quarters · filed 2024-02-28 | $10.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.19M derived: sum of 2 quarters · filed 2024-02-28 | $7.89M derived: sum of 3 quarters · filed 2024-02-28 | $7.98M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $5.05M derived: sum of 2 quarters · filed 2022-11-02 | $5.13M 10-Q · filed 2022-11-02 | $6.51M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.79M 10-Q · filed 2022-08-03 | $4.16M derived: sum of 3 quarters · filed 2023-02-22 | $5.96M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $84.00K 10-Q · filed 2022-05-04 | $1.46M derived: sum of 2 quarters · filed 2023-02-22 | $3.25M derived: sum of 3 quarters · filed 2023-02-22 | $5.09M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.17M derived: sum of 2 quarters · filed 2023-02-22 | $5.01M derived: sum of 3 quarters · filed 2023-02-22 | $7.16M 10-K · filed 2023-02-22 |
| 2020-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.63M derived: sum of 2 quarters · filed 2021-11-09 | $5.79M 10-Q · filed 2021-11-09 | $7.48M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.99M 10-Q · filed 2021-08-05 | $5.68M derived: sum of 3 quarters · filed 2022-02-24 | $7.93M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $2.15M 10-Q · filed 2021-05-06 | $3.84M derived: sum of 2 quarters · filed 2022-02-24 | $6.09M derived: sum of 3 quarters · filed 2022-02-24 | $7.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.94M derived: sum of 2 quarters · filed 2022-02-24 | $5.45M derived: sum of 3 quarters · filed 2022-02-24 | $6.17M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.76M derived: sum of 2 quarters · filed 2020-11-06 | $4.48M 10-Q · filed 2020-11-06 | $5.89M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.23M 10-Q · filed 2020-08-07 | $3.65M derived: sum of 3 quarters · filed 2021-02-26 | $4.58M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $718.00K 10-Q · filed 2020-05-08 | $2.13M derived: sum of 2 quarters · filed 2021-02-26 | $3.07M derived: sum of 3 quarters · filed 2021-02-26 | $4.46M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.35M derived: sum of 2 quarters · filed 2021-02-26 | $3.74M derived: sum of 3 quarters · filed 2021-02-26 | $4.75M 10-K · filed 2021-02-26 |
| 2018-09-30 | $938.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.33M derived: sum of 2 quarters · filed 2019-11-12 | $3.34M 10-Q · filed 2019-11-12 | $3.63M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.40M 10-Q · filed 2019-08-07 | $2.69M derived: sum of 3 quarters · filed 2020-02-26 | $3.44M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $1.01M 10-Q · filed 2019-05-08 | $1.30M derived: sum of 2 quarters · filed 2020-02-26 | $2.05M derived: sum of 3 quarters · filed 2020-02-26 | $2.41M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.04M derived: sum of 2 quarters · filed 2020-02-26 | $1.40M derived: sum of 3 quarters · filed 2020-02-26 | $2.06M 10-K · filed 2020-02-26 |
| 2017-09-30 | $752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.11M derived: sum of 2 quarters · filed 2018-11-08 | $1.77M 10-Q · filed 2018-11-08 | $2.45M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.02M 10-Q · filed 2018-08-07 | $1.69M derived: sum of 3 quarters · filed 2019-03-01 | $2.41M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $656.00K 10-Q · filed 2018-05-04 | $1.33M derived: sum of 2 quarters · filed 2019-03-01 | $2.04M derived: sum of 3 quarters · filed 2019-03-01 | $3.21M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.39M derived: sum of 2 quarters · filed 2019-03-01 | $2.55M derived: sum of 3 quarters · filed 2019-03-01 | $3.49M 10-K · filed 2019-03-01 |
| 2016-09-30 | $713.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.87M derived: sum of 2 quarters · filed 2017-11-08 | $2.82M 10-Q · filed 2017-11-08 | $3.22M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.10M 10-Q · filed 2017-08-09 | $2.50M derived: sum of 3 quarters · filed 2018-03-08 | $2.69M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $943.00K 10-Q · filed 2017-05-15 | $1.34M derived: sum of 2 quarters · filed 2018-03-08 | $1.53M derived: sum of 3 quarters · filed 2018-03-08 | $2.07M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $591.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.13M derived: sum of 3 quarters · filed 2018-03-08 | $1.43M 10-K · filed 2018-03-08 |
| 2015-09-30 | $190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $725.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.03M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $535.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $840.00K 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | $305.00K 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | $1.22M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |